The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Acamprosate Calcium Market Research Report 2024
Synopsis
Acamprosate calcium delayed-release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with acamprosate calcium delayed-release tablets should be part of a comprehensive management program that includes psychosocial support.
The global Acamprosate Calcium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Acamprosate Calcium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Acamprosate Calcium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Acamprosate Calcium include Merck Group, Zydus Pharmaceuticals, Mylan, Teva and Glenmark Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Acamprosate Calcium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acamprosate Calcium.
Report Scope
The Acamprosate Calcium market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acamprosate Calcium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acamprosate Calcium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Group
Zydus Pharmaceuticals
Mylan
Teva
Glenmark Pharmaceuticals
Segment by Type
333mg
666mg
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acamprosate Calcium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acamprosate Calcium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Acamprosate calcium delayed-release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with acamprosate calcium delayed-release tablets should be part of a comprehensive management program that includes psychosocial support.
The global Acamprosate Calcium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Acamprosate Calcium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Acamprosate Calcium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Acamprosate Calcium include Merck Group, Zydus Pharmaceuticals, Mylan, Teva and Glenmark Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Acamprosate Calcium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acamprosate Calcium.
Report Scope
The Acamprosate Calcium market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acamprosate Calcium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acamprosate Calcium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Group
Zydus Pharmaceuticals
Mylan
Teva
Glenmark Pharmaceuticals
Segment by Type
333mg
666mg
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acamprosate Calcium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acamprosate Calcium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Acamprosate Calcium Market Overview
1.1 Product Overview and Scope of Acamprosate Calcium
1.2 Acamprosate Calcium Segment by Type
1.2.1 Global Acamprosate Calcium Market Value Comparison by Type (2024-2030)
1.2.2 333mg
1.2.3 666mg
1.3 Acamprosate Calcium Segment by Application
1.3.1 Global Acamprosate Calcium Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Acamprosate Calcium Market Size Estimates and Forecasts
1.4.1 Global Acamprosate Calcium Revenue 2019-2030
1.4.2 Global Acamprosate Calcium Sales 2019-2030
1.4.3 Global Acamprosate Calcium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Acamprosate Calcium Market Competition by Manufacturers
2.1 Global Acamprosate Calcium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Acamprosate Calcium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Acamprosate Calcium Average Price by Manufacturers (2019-2024)
2.4 Global Acamprosate Calcium Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Acamprosate Calcium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acamprosate Calcium, Product Type & Application
2.7 Acamprosate Calcium Market Competitive Situation and Trends
2.7.1 Acamprosate Calcium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Acamprosate Calcium Players Market Share by Revenue
2.7.3 Global Acamprosate Calcium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Acamprosate Calcium Retrospective Market Scenario by Region
3.1 Global Acamprosate Calcium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Acamprosate Calcium Global Acamprosate Calcium Sales by Region: 2019-2030
3.2.1 Global Acamprosate Calcium Sales by Region: 2019-2024
3.2.2 Global Acamprosate Calcium Sales by Region: 2025-2030
3.3 Global Acamprosate Calcium Global Acamprosate Calcium Revenue by Region: 2019-2030
3.3.1 Global Acamprosate Calcium Revenue by Region: 2019-2024
3.3.2 Global Acamprosate Calcium Revenue by Region: 2025-2030
3.4 North America Acamprosate Calcium Market Facts & Figures by Country
3.4.1 North America Acamprosate Calcium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Acamprosate Calcium Sales by Country (2019-2030)
3.4.3 North America Acamprosate Calcium Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Acamprosate Calcium Market Facts & Figures by Country
3.5.1 Europe Acamprosate Calcium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Acamprosate Calcium Sales by Country (2019-2030)
3.5.3 Europe Acamprosate Calcium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acamprosate Calcium Market Facts & Figures by Country
3.6.1 Asia Pacific Acamprosate Calcium Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Acamprosate Calcium Sales by Country (2019-2030)
3.6.3 Asia Pacific Acamprosate Calcium Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Acamprosate Calcium Market Facts & Figures by Country
3.7.1 Latin America Acamprosate Calcium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Acamprosate Calcium Sales by Country (2019-2030)
3.7.3 Latin America Acamprosate Calcium Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acamprosate Calcium Market Facts & Figures by Country
3.8.1 Middle East and Africa Acamprosate Calcium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Acamprosate Calcium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Acamprosate Calcium Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Acamprosate Calcium Sales by Type (2019-2030)
4.1.1 Global Acamprosate Calcium Sales by Type (2019-2024)
4.1.2 Global Acamprosate Calcium Sales by Type (2025-2030)
4.1.3 Global Acamprosate Calcium Sales Market Share by Type (2019-2030)
4.2 Global Acamprosate Calcium Revenue by Type (2019-2030)
4.2.1 Global Acamprosate Calcium Revenue by Type (2019-2024)
4.2.2 Global Acamprosate Calcium Revenue by Type (2025-2030)
4.2.3 Global Acamprosate Calcium Revenue Market Share by Type (2019-2030)
4.3 Global Acamprosate Calcium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Acamprosate Calcium Sales by Application (2019-2030)
5.1.1 Global Acamprosate Calcium Sales by Application (2019-2024)
5.1.2 Global Acamprosate Calcium Sales by Application (2025-2030)
5.1.3 Global Acamprosate Calcium Sales Market Share by Application (2019-2030)
5.2 Global Acamprosate Calcium Revenue by Application (2019-2030)
5.2.1 Global Acamprosate Calcium Revenue by Application (2019-2024)
5.2.2 Global Acamprosate Calcium Revenue by Application (2025-2030)
5.2.3 Global Acamprosate Calcium Revenue Market Share by Application (2019-2030)
5.3 Global Acamprosate Calcium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Group
6.1.1 Merck Group Corporation Information
6.1.2 Merck Group Description and Business Overview
6.1.3 Merck Group Acamprosate Calcium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Group Acamprosate Calcium Product Portfolio
6.1.5 Merck Group Recent Developments/Updates
6.2 Zydus Pharmaceuticals
6.2.1 Zydus Pharmaceuticals Corporation Information
6.2.2 Zydus Pharmaceuticals Description and Business Overview
6.2.3 Zydus Pharmaceuticals Acamprosate Calcium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zydus Pharmaceuticals Acamprosate Calcium Product Portfolio
6.2.5 Zydus Pharmaceuticals Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Acamprosate Calcium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Acamprosate Calcium Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Acamprosate Calcium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Acamprosate Calcium Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Glenmark Pharmaceuticals
6.5.1 Glenmark Pharmaceuticals Corporation Information
6.5.2 Glenmark Pharmaceuticals Description and Business Overview
6.5.3 Glenmark Pharmaceuticals Acamprosate Calcium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Glenmark Pharmaceuticals Acamprosate Calcium Product Portfolio
6.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acamprosate Calcium Industry Chain Analysis
7.2 Acamprosate Calcium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acamprosate Calcium Production Mode & Process
7.4 Acamprosate Calcium Sales and Marketing
7.4.1 Acamprosate Calcium Sales Channels
7.4.2 Acamprosate Calcium Distributors
7.5 Acamprosate Calcium Customers
8 Acamprosate Calcium Market Dynamics
8.1 Acamprosate Calcium Industry Trends
8.2 Acamprosate Calcium Market Drivers
8.3 Acamprosate Calcium Market Challenges
8.4 Acamprosate Calcium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
